Background: Literature supporting MRI for upfront prostate cancer screening in lieu of a traditional PSA-triggered strategy has been performed primarily within clinical trial settings in North American and European populations.
No takes yet. Share an insight, caveat, or question.
Joo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: